🚀 RECENT AI SUCCESS
Our AI successfully predicted the gap for $PUB.PA and executed a BUY strategy, securing a +9.52% net profit.
UPGRADE TO SEE LIVE SIGNALS
$GMAB.CO
Genmab A/S
FREE PREVIEW
📅 Next Earnings: Aug 06, 2026 🌙 Close🌐 Website🏛️ Nasdaq Copenhagen📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP0.82%
MAX GAP RECORD9.99%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
VOLATILITY & BIAS PROFILE
AVG VOLATILITY2.7%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment… Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL